Actinium Pharmaceuticals Inc (ATNM)

Actinium Pharmaceuticals Inc (ATNM) is a Biotechnology company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $30.6M; returns 1 day -5.0%, 1 week +34.5%, 1 year +6.3%.

Actinium Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing targeted radiotherapies for cancer patients with limited treatment options. The company utilizes proprietary technology platforms to create Antibody Radiation Conjugates (ARCs), which involve monoclonal antibodies delivering radioisotopes directly to cancer cells.

Groups ATNM belongs to

• Biotechnology
• Clinical Stage Biotech
• Biopharmaceutical
• Oncology
• Antibody-Drug Conjugates
• Healthcare
• Cancer Therapeutics
• Monoclonal Antibodies
• Life Sciences
• Hematologic Malignancies
• Hematology
• Precision Medicine

ATNM financial model: income statement, cash flow and balance sheet